Armata Pharmaceuticals Stock Analysis
| ARMP Stock | USD 1.68 0.16 8.70% |
Armata Pharmaceuticals is undervalued with Real Value of 2.98 and Hype Value of 1.69. The main objective of Armata Pharmaceuticals stock analysis is to determine its intrinsic value, which is an estimate of what Armata Pharmaceuticals is worth, separate from its market price. There are two main types of Armata Pharmaceuticals' stock analysis: fundamental analysis and technical analysis.
The Armata Pharmaceuticals stock is traded in the USA on NYSE MKT Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Armata Pharmaceuticals is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, National Mourning Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Armata Stock trading window is adjusted to America/New York timezone.
Armata |
Armata Stock Analysis Notes
About 70.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.89. Armata Pharmaceuticals last dividend was issued on the 10th of May 2019. The entity had 1:14 split on the 10th of May 2019. Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It has a partnership agreement with Merck Co. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. Armata Pharmaceuticals operates under Biotechnology classification in the United States and is traded on AMEX Exchange. It employs 69 people. For more info on Armata Pharmaceuticals please contact Deborah MD at 310 665 2928 or go to https://www.armatapharma.com.Armata Pharmaceuticals Investment Alerts
| Armata Pharmaceuticals generated a negative expected return over the last 90 days | |
| Armata Pharmaceuticals may become a speculative penny stock | |
| Armata Pharmaceuticals has high historical volatility and very poor performance | |
| Armata Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (18.92 M) with loss before overhead, payroll, taxes, and interest of (28.05 M). | |
| Armata Pharmaceuticals currently holds about 36.98 M in cash with (37.55 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.02. | |
| Armata Pharmaceuticals has a frail financial position based on the latest SEC disclosures | |
| Roughly 70.0% of the company shares are held by company insiders |
Armata Pharmaceuticals Upcoming and Recent Events
| 21st of March 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 21st of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Armata Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 66.58 M.Technical Drivers
As of the 25th of March, Armata Pharmaceuticals shows the Standard Deviation of 3.71, risk adjusted performance of (0.05), and Mean Deviation of 2.74. Armata Pharmaceuticals technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Armata Pharmaceuticals Price Movement Analysis
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Armata Pharmaceuticals middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Armata Pharmaceuticals. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Armata Pharmaceuticals Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Armata Pharmaceuticals insiders, such as employees or executives, is commonly permitted as long as it does not rely on Armata Pharmaceuticals' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Armata Pharmaceuticals insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Armata Pharmaceuticals Outstanding Bonds
Armata Pharmaceuticals issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Armata Pharmaceuticals uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Armata bonds can be classified according to their maturity, which is the date when Armata Pharmaceuticals has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Armata Pharmaceuticals Predictive Daily Indicators
Armata Pharmaceuticals intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Armata Pharmaceuticals stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 6695.08 | |||
| Daily Balance Of Power | (0.64) | |||
| Rate Of Daily Change | 0.91 | |||
| Day Median Price | 1.76 | |||
| Day Typical Price | 1.73 | |||
| Price Action Indicator | (0.16) | |||
| Period Momentum Indicator | (0.16) |
Armata Pharmaceuticals Forecast Models
Armata Pharmaceuticals' time-series forecasting models are one of many Armata Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Armata Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Armata Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Armata Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Armata shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Armata Pharmaceuticals. By using and applying Armata Stock analysis, traders can create a robust methodology for identifying Armata entry and exit points for their positions.
Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It has a partnership agreement with Merck Co. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. Armata Pharmaceuticals operates under Biotechnology classification in the United States and is traded on AMEX Exchange. It employs 69 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Armata Pharmaceuticals to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Stocks Directory Now
Stocks DirectoryFind actively traded stocks across global markets |
| All Next | Launch Module |
Additional Tools for Armata Stock Analysis
When running Armata Pharmaceuticals' price analysis, check to measure Armata Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Armata Pharmaceuticals is operating at the current time. Most of Armata Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Armata Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Armata Pharmaceuticals' price. Additionally, you may evaluate how the addition of Armata Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.